Skip to main content

Table 1 Focus group participant characteristics

From: How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathy

Gender Age Race eGFR (mL/min/1.73m2) Proteinuria (g/d) Kidney biopsy Ever treated with immuno-suppression Currently on immuno-suppression On renin-angiotensin system blocker
Male 55 Caucasian 29 0.40 Sept 2009 Yes Yes Yes
Male 41 Caucasian 60 0.63 Apr 1998 No No Yes
Male 47 Caucasian 55 0.36 Oct 2014 Yes Yes Yes
Male 35 Caucasian 71 1.41 Sept 2011 Yes No Yes
Male 54 Caucasian 56 0.65 Oct 2016 Yes No Yes